<DOC>
	<DOCNO>NCT01374698</DOCNO>
	<brief_summary>This prospective , randomize study conduct patient undergo coronary revascularization procedure ( PCI ) angioplasty . All patient meet eligibility criterion randomize receive , procedure , oral aspirin reload ( 325 mg ) re-evaluated 60 minute , 120 minute , 6 hour , 48 hour , 5 30 day , 3 6 month .</brief_summary>
	<brief_title>Aspirin Reload Before Percutaneous Coronary Intervention : Reperfusion Indexes Evaluation .</brief_title>
	<detailed_description>Study population compose 60 patient native coronary chronic occlusion vessel diameter equal superior 3 mm . The vessel must treat balloon angioplasty must completely cover two stent maximum maximum length ≤ 33 mm . The native coronary chronic occlusion define native coronary obstruction , establish least 30 day , without lumen continuity `` Thrombolysis In Myocardial Infarction '' ( TIMI ) flow grade equal superior 1 . Patient must treat chronic ( least 7 day ) oral 100 mg/die aspirin treatment . After eligibility criterion confirmation , patient randomize 1:1 ratio receive aspirin reload . Coronary angiography evaluate centralized laboratory Coronary Quantitative Angiography method . Myocardial necrosis index , ejection fraction , TIMI frame count ( TFC ) myocardial blush grade ( MBG ) variation represent short term primary end-points . Clinical event incidence , include death , myocardial infarction , target vessel revascularization stent thrombosis , evaluate 1 , 6 12 month . Study design In every patient perform baseline blood sample collection evaluate inflammation , platelet activation oxidative stress index . After baseline collection blood sample , computer-generated random sequence use randomization oral aspirin reload administration . Every patient , guideline describe , receive oral clopidogrel reload ( 300 mg ) turn 75 mg/die oral administration next 6 month . After procedure , patient turn back chronic aspirin 100 mg/die oral treatment . After percutaneous access obtain , administered 5000 U unfractioned heparin bolus , treat dose obtain clotting time equal superior 250 second intervention . A basal angiography perform least two orthogonal adjoin projection use diagnostic 6F catheter . Every angiogram must include least 2 cm catheter length allow accurate quantitative coronary angiographic evaluation . Target lesion cross 0,0014 '' metallic guide single proper-dimensions-balloon predilatation perform inflating nominal pression balloon 15 second long . In 1 minute dilatation implant sirolimus elute stent ( SES ; Cypher ™ , Cordis , Johnson &amp; Johnson ) . Stent deployment obtain high pressure 10 second balloon inflate ( 15 atm ) without second dilatation . No direct stent implantation realize . TFC MBG evaluate procedure . At 60 120 minute 6 hour procedure blood sample collection perform evaluate baseline index . After 48 hour , 5 30 day ejection fraction re-evaluated . Every 3 month , 12 month least , patient receive ambulatorial follow recognize new ischemic symptom instrumental sign onset . Statistical Considerations Previous observation report revascularization procedure observe 35 % plasmatic thromboxane level increase ( vivo platelet activation index ) patient receive chronic aspirin treatment ( 7 day ) . Hypothesizing oral aspirin reload could produce 25 % absolute reduction plasmatic thromboxane level ( 10 % ) study need 50 patient every treatment arm sample size ( 1-beta=90 % ; alfa=5 % ) .</detailed_description>
	<mesh_term>Arteriosclerosis</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>De novo native coronary chronic occlusion reference diameter equal superior 3 mm program treatment ; 100 mg/die oral aspirin treatment least 7 day procedure ; Target lesion must cover two stent maximum maximum length ≤ 33 mm Signed write informed consent Aspirin , bisulphate clopidogrel , ticlopidine , heparin , contrast agent heavy metal know allergy medically handle ; Target occlusion localize inside previously implant graft Target occlusion localize inside vessel segment previously underwent stentpositioning Target occlusion localize inside vessel occlusion nottobe treat target occlusion stent ( ) Target occlusion localize inside vessel occlusion need treat balloon angioplasty Other technique balloon angioplasty target occlusion pretreatment atherectomy , laser intervention thrombectomy Coronary brachytherapy treat patient Ejection fraction equal minor 30 % Renal insufficiency ( creatinine &gt; 3.0 mg/dl ) Warfarintreated patient Life expectancy minor 12 month Heart transplant patient Patients still enrol study , pharmacological</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>PCI</keyword>
	<keyword>Aspirin</keyword>
	<keyword>Reload</keyword>
</DOC>